<p>This study aimed to construct a nomogram for predicting overall survival in patients with bone metastases (BM) from hepatocellular carcinoma (HCC), leveraging data from the Surveillance, Epidemiology, and End Results (SEER) database spanning the period from 2010 to 2015. The patient cohort was randomly partitioned into a training set (<i>n</i> = 338) and a validation set (<i>n</i> = 145). Kaplan–Meier analysis and multivariate Cox proportional hazards regression identified marital status, liver surgery, and radiotherapy/chemotherapy as significant prognostic factors (<i>P</i> ≤ 0.05), which were subsequently integrated into the nomogram. The nomogram exhibited a concordance index of 0.72 (95% confidence interval: 0.70–0.75) and demonstrated robust calibration between predicted and observed survival rates. This nomogram has the potential to accurately forecast prognosis and assist clinicians in formulating appropriate treatment strategies for patients with HCC bone metastasis.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study

  • Qingliang Song,
  • Yilin Kong,
  • Chuiyang Zheng,
  • Dajin Pi,
  • Wen Fan,
  • Jianwei Zhen,
  • Jinyue Pan,
  • Lianghao Liu,
  • Siyuan Huang,
  • Fangyu Zhou,
  • Qinhe Yang,
  • Yupei Zhang,
  • Maoxing Pan

摘要

This study aimed to construct a nomogram for predicting overall survival in patients with bone metastases (BM) from hepatocellular carcinoma (HCC), leveraging data from the Surveillance, Epidemiology, and End Results (SEER) database spanning the period from 2010 to 2015. The patient cohort was randomly partitioned into a training set (n = 338) and a validation set (n = 145). Kaplan–Meier analysis and multivariate Cox proportional hazards regression identified marital status, liver surgery, and radiotherapy/chemotherapy as significant prognostic factors (P ≤ 0.05), which were subsequently integrated into the nomogram. The nomogram exhibited a concordance index of 0.72 (95% confidence interval: 0.70–0.75) and demonstrated robust calibration between predicted and observed survival rates. This nomogram has the potential to accurately forecast prognosis and assist clinicians in formulating appropriate treatment strategies for patients with HCC bone metastasis.